JPY 2388.0
(0.55%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 11.55 Billion JPY | 0.17% |
2022 | 11.53 Billion JPY | 0.52% |
2021 | 11.47 Billion JPY | -2.44% |
2020 | 11.76 Billion JPY | -0.25% |
2019 | 11.79 Billion JPY | -3.11% |
2018 | 12.16 Billion JPY | -2.43% |
2017 | 12.47 Billion JPY | -0.97% |
2016 | 12.59 Billion JPY | 2.77% |
2015 | 12.25 Billion JPY | 0.45% |
2014 | 12.19 Billion JPY | 2.65% |
2013 | 11.88 Billion JPY | 3.35% |
2012 | 11.49 Billion JPY | -1.83% |
2011 | 11.71 Billion JPY | 0.64% |
2010 | 11.63 Billion JPY | -13.36% |
2009 | 13.43 Billion JPY | 47.61% |
2008 | 9.1 Billion JPY | 8.18% |
2007 | 8.41 Billion JPY | 6.13% |
2006 | 7.92 Billion JPY | -4.51% |
2005 | 8.3 Billion JPY | 7.08% |
2004 | 7.75 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 3.02 Billion JPY | 0.43% |
2023 Q2 | 2.86 Billion JPY | -1.75% |
2023 Q1 | 2.91 Billion JPY | 1.6% |
2023 Q4 | 3 Billion JPY | -2.56% |
2023 FY | 11.55 Billion JPY | 0.17% |
2023 Q3 | 3.08 Billion JPY | 7.86% |
2022 Q2 | 2.86 Billion JPY | -1.14% |
2022 Q4 | 2.86 Billion JPY | -1.38% |
2022 Q1 | 2.89 Billion JPY | -4.2% |
2022 Q3 | 2.9 Billion JPY | 1.61% |
2022 FY | 11.53 Billion JPY | 0.52% |
2021 Q4 | 3.02 Billion JPY | 3.28% |
2021 FY | 11.47 Billion JPY | -2.44% |
2021 Q3 | 2.92 Billion JPY | 9.51% |
2021 Q1 | 2.85 Billion JPY | -2.23% |
2021 Q2 | 2.67 Billion JPY | -6.34% |
2020 Q4 | 2.91 Billion JPY | -8.04% |
2020 Q1 | 2.78 Billion JPY | -1.59% |
2020 Q2 | 2.88 Billion JPY | 3.41% |
2020 FY | 11.76 Billion JPY | -0.25% |
2020 Q3 | 3.17 Billion JPY | 10.1% |
2019 FY | 11.79 Billion JPY | -3.11% |
2019 Q4 | 2.83 Billion JPY | -5.66% |
2019 Q2 | 3.02 Billion JPY | 2.86% |
2019 Q1 | 2.93 Billion JPY | -0.98% |
2019 Q3 | 3 Billion JPY | -0.6% |
2018 Q3 | 3.09 Billion JPY | 3.89% |
2018 FY | 12.16 Billion JPY | -2.43% |
2018 Q1 | 3.12 Billion JPY | 2.97% |
2018 Q2 | 2.98 Billion JPY | -4.42% |
2018 Q4 | 2.96 Billion JPY | -4.32% |
2017 Q1 | 3.16 Billion JPY | 0.41% |
2017 FY | 12.47 Billion JPY | -0.97% |
2017 Q3 | 3.12 Billion JPY | -0.7% |
2017 Q2 | 3.14 Billion JPY | -0.66% |
2017 Q4 | 3.03 Billion JPY | -3.01% |
2016 Q1 | 3.21 Billion JPY | 6.36% |
2016 FY | 12.59 Billion JPY | 2.77% |
2016 Q4 | 3.15 Billion JPY | -0.69% |
2016 Q3 | 3.17 Billion JPY | 4.13% |
2016 Q2 | 3.05 Billion JPY | -4.95% |
2015 FY | 12.25 Billion JPY | 0.45% |
2015 Q4 | 3.01 Billion JPY | -0.43% |
2015 Q3 | 3.03 Billion JPY | -6.1% |
2015 Q2 | 3.22 Billion JPY | 8.43% |
2015 Q1 | 2.97 Billion JPY | -0.43% |
2014 Q3 | 3.1 Billion JPY | 3.43% |
2014 Q4 | 2.99 Billion JPY | -3.73% |
2014 FY | 12.19 Billion JPY | 2.65% |
2014 Q1 | 3.1 Billion JPY | 2.07% |
2014 Q2 | 3 Billion JPY | -3.13% |
2013 Q2 | 2.88 Billion JPY | -2.53% |
2013 Q4 | 3.03 Billion JPY | 1.3% |
2013 FY | 11.88 Billion JPY | 3.35% |
2013 Q1 | 2.96 Billion JPY | 2.6% |
2013 Q3 | 2.99 Billion JPY | 3.84% |
2012 Q3 | 2.94 Billion JPY | 6.08% |
2012 Q4 | 2.88 Billion JPY | -2.1% |
2012 Q1 | 2.88 Billion JPY | -3.32% |
2012 FY | 11.49 Billion JPY | -1.83% |
2012 Q2 | 2.78 Billion JPY | -3.57% |
2011 Q1 | 2.97 Billion JPY | 4.31% |
2011 Q2 | 2.84 Billion JPY | -4.57% |
2011 Q3 | 2.91 Billion JPY | 2.43% |
2011 Q4 | 2.98 Billion JPY | 2.44% |
2011 FY | 11.71 Billion JPY | 0.64% |
2010 Q3 | 2.9 Billion JPY | 2.4% |
2010 Q2 | 2.83 Billion JPY | -7.08% |
2010 FY | 11.63 Billion JPY | -13.36% |
2010 Q4 | 2.85 Billion JPY | -1.59% |
2010 Q1 | 3.04 Billion JPY | 2.18% |
2009 Q1 | 3.53 Billion JPY | 509.86% |
2009 Q4 | 2.98 Billion JPY | -11.64% |
2009 Q3 | 3.37 Billion JPY | -4.58% |
2009 Q2 | 3.53 Billion JPY | 0.17% |
2009 FY | 13.43 Billion JPY | 47.61% |
2008 Q2 | 3.26 Billion JPY | 0.0% |
2008 FY | 9.1 Billion JPY | 8.18% |
2008 Q4 | -862 Million JPY | -125.7% |
2008 Q3 | 3.35 Billion JPY | 2.79% |
2007 FY | 8.41 Billion JPY | 6.13% |
2006 FY | 7.92 Billion JPY | -4.51% |
2005 FY | 8.3 Billion JPY | 7.08% |
2004 FY | 7.75 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 43.63 Billion JPY | 73.526% |
Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 99.559% |
Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 97.869% |
Shionogi & Co., Ltd. | 197.62 Billion JPY | 94.154% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -209.205% |
Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 82.397% |
Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | 60.198% |
Eisai Co., Ltd. | 533.01 Billion JPY | 97.832% |
Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -118.724% |
Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 82.443% |
Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 75.03% |
Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -40.343% |
Tsumura & Co. | 48.8 Billion JPY | 76.326% |
Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | 65.331% |
Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | 40.866% |
Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 81.874% |
Fuji Pharma Co., Ltd. | 12.65 Billion JPY | 8.722% |
Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | 71.449% |
KYORIN Holdings, Inc. | 45.39 Billion JPY | 74.55% |
Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -177.917% |
Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -94.331% |
SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -121.208% |
MedRx Co., Ltd | 959 Million JPY | -1104.692% |
Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -302.021% |
Solasia Pharma K.K. | 1.47 Billion JPY | -682.724% |
Modalis Therapeutics Corporation | 2.37 Billion JPY | -387.332% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | 52.191% |
Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | 67.395% |
Cyfuse Biomedical K.K. | 735.18 Million JPY | -1471.45% |
Toho Holdings Co., Ltd. | 99.81 Billion JPY | 88.426% |
Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -411.809% |